학술논문
Feasibility of combining temsirolimus to vincristine, dactinomycin, cyclophosphamide, and vincristine and irinotecan chemotherapy for children with intermediate‐risk rhabdomyosarcoma: A report from Children's Oncology Group.
Document Type
Article
Author
Source
Pediatric Blood & Cancer; Sep2023, Vol. 70 Issue 9, p1-8, 8p
Subject
Language
ISSN
15455009